VESALIUS-CV: evolocumab e prevenzione cardiovascolare nel diabete - A cura di L. Sacchetta, I. Milani, G. Della Pepa

from Le Voci del Journal Club SID · host Società Italiana Diabetologia

Evolocumab to Reduce First Major Cardiovascular Events in Patients Without Known Significant Atherosclerosis and With Diabetes Results From the VESALIUS-CV Trial. A cura di Luca Sacchetta, Ilaria Milani e Giuseppe Della PepaArticolo di riferimento: Nicholas A. Marston, Erin A. Bohula, Ajay K. Bhatia, et al. Investigators. Evolocumab to Reduce First Major Cardiovascular Events in Patients Without Known Significant Atherosclerosis and With Diabetes Results From the VESALIUS-CV Trial. JAMA 16, 335 (2026). https:// doi:10.1001/jama.2026.3277

Episode metadata supplied by the publisher feed · Published Jun 12, 2026

Embed this episode

Attribution link and audio player

Ready to play

VESALIUS-CV: evolocumab e prevenzione cardiovascolare nel diabete - A cura di L. Sacchetta, I. Milani, G. Della Pepa

0:00 2:55

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Le Voci del Journal Club SID?

This episode is 2 minutes long.

When was this Le Voci del Journal Club SID episode published?

This episode was published on June 12, 2026.

Can I download this Le Voci del Journal Club SID episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!